Correlation Between Crispr Therapeutics and CureVac NV
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and CureVac NV, you can compare the effects of market volatilities on Crispr Therapeutics and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and CureVac NV.
Diversification Opportunities for Crispr Therapeutics and CureVac NV
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Crispr and CureVac is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and CureVac NV go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and CureVac NV
Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 1.25 times more return on investment than CureVac NV. However, Crispr Therapeutics is 1.25 times more volatile than CureVac NV. It trades about 0.03 of its potential returns per unit of risk. CureVac NV is currently generating about -0.07 per unit of risk. If you would invest 4,600 in Crispr Therapeutics AG on August 24, 2024 and sell it today you would earn a total of 29.00 from holding Crispr Therapeutics AG or generate 0.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. CureVac NV
Performance |
| Timeline |
| Crispr Therapeutics |
| CureVac NV |
Crispr Therapeutics and CureVac NV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and CureVac NV
The main advantage of trading using opposite Crispr Therapeutics and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| CureVac NV vs. ZyVersa Therapeutics | CureVac NV vs. Sonnet Biotherapeutics Holdings | CureVac NV vs. Zura Bio Limited | CureVac NV vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |